Scott Stromatt, EVP, Clinical Development & Reg Affair at CELL THERAPEUTICS INC (CTIC), sold 2,500 shares at $1.54 ($4K) on 2006-08-30, disclosed to the SEC on 2006-09-01.
Scheduled sale ($4k) by EVP, Clinical Development & Reg Affair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTIC | SELL | 2006-12-15 | $14K | — | Filing → |
| CTIC | SELL | 2006-06-22 | $28K | — | Filing → |